Table 2.
All-Cause and Cause-Specific Standardized Mortality Ratios in 5-Year Survivors of Childhood Cancer
Characteristic | All Causes |
Subsequent Malignancy |
Cardiac Causes |
Pulmonary Causes |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Deaths | SMR | 95% CI | P* | No. of Deaths | SMR | 95% CI | P* | No. of Deaths | SMR | 95% CI | P* | No. of Deaths | SMR | 95% CI | P* | |
All patients | 2,076 | 8.89 | 8.52 to 9.29 | 205 | 8.02 | 6.96 to 9.19 | 103 | 6.05 | 4.94 to 7.34 | 29 | 7.32 | 4.90 to 10.51 | ||||
Sex | < .001 | .19 | .89 | .03 | ||||||||||||
Male | 1,214 | 7.64 | 7.22 to 8.08 | 104 | 8.81 | 7.20 to 10.68 | 68 | 6.12 | 4.75 to 7.75 | 21 | 10.10 | 6.25 to 15.43 | ||||
Female | 862 | 11.57 | 10.81 to 12.37 | 101 | 7.33 | 5.97 to 8.91 | 35 | 5.93 | 4.13 to 8.25 | 8 | 4.25 | 1.83 to 8.38 | ||||
Year of diagnosis | < .001 | .04 | .03 | .83 | ||||||||||||
1974-1980 | 825 | 7.52 | 7.02 to 8.05 | 121 | 8.18 | 6.79 to 9.77 | 46 | 4.65 | 3.40 to 6.20 | 16 | 7.70 | 4.40 to 12.51 | ||||
1981-1987 | 617 | 8.82 | 8.14 to 9.54 | 42 | 6.29 | 4.53 to 8.51 | 40 | 8.72 | 6.23 to 11.88 | 8 | 7.18 | 3.09 to 14.15 | ||||
1988-1994 | 419 | 10.32 | 9.36 to 11.36 | 37 | 11.63 | 8.19 to 16.04 | 15 | 7.47 | 4.18 to 12.32 | 3 | 5.04 | 1.01 to 14.72 | ||||
1995-2000 | 215 | 16.35 | 14.24 to 18.69 | 5 | 5.40 | 1.74 to 12.60 | 2 | 3.77 | 0.42 to 13.63 | 2 | 11.47 | 1.29 to 41.41 | ||||
Race/ethnicity | < .001 | < .001 | .15 | .19 | ||||||||||||
White | 1,699 | 8.92 | 8.50 to 9.36 | 156 | 7.12 | 6.05 to 8.33 | 87 | 6.41 | 5.13 to 7.91 | 22 | 7.27 | 4.55 to 11.00 | ||||
Black | 229 | 6.67 | 5.84 to 7.59 | 29 | 10.72 | 7.18 to 15.40 | 11 | 3.71 | 1.85 to 6.65 | 4 | 5.01 | 1.35 to 12.83 | ||||
Asian, Pacific Islander, American Indian, Alaskan native | 144 | 16.60 | 14.00 to 19.55 | 20 | 20.73 | 12.66 to 32.02 | 4 | 8.31 | 2.24 to 21.28 | 3 | 22.25 | 4.47 to 65.02 |
NOTE. As of December 31, 2005. All SMRs were age-, sex-, and race-standardized according to the US mortality rates from the SEER Program. “Subsequent malignancy” refers to a new neoplasm. Cancer deaths resulting from progression of the original cancer are not included in the observed number of events.
Abbreviations: SMR, standardized mortality ratio; SEER, Surveillance, Epidemiology, and End Results.
P from test for heterogeneity.